RegisterLogin

BSO-07

CAT: 931-T200451-01Size: 10 mgDry Ice: NoHazardous: No
10 mgSelected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Target
JNK|||Reactive Oxygen Species
Related Pathways
Immunology/Inflammation|||Metabolism|||NF-?B|||MAPK
Bioactivity
BSO-07 is a ROS/JNK activator that exhibits potent anti-cancer properties, demonstrated by an IC50 of 24.81 ?M in human breast cancer (BC) cells. The mechanism of action for BSO-07 involves JNK activation and the promotion of increased ROS levels, which lead to the induction of apoptosis (Apoptosis) and tumorigenic apoptosis. This includes enhanced expression of apoptosis-related proteins such as PARP, Bax, phosphorylated p53, ATF4, and CHOP, along with a reduction in the levels of anti-apoptotic proteins (e.g., Bcl-2, Bcl-xL, and Survivin) . BSO-07 holds promise for research in the field of breast cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
T69727-01ADA-07
T73483-01RMS-07
T23657-01AFP-07
T89581-01JZD-07
TQ0052-01SH5-07
TP2000MM 07
T8554-01KCC-07
T78837-01CP-07
T24858-01TBZ-07
T70401-01HOI-07

Alternative Products

CatalogName
HY-162886BSO-07
C14446-01BSO
STJ501223Anti-07/02/07
C18069SH5-07 (SH-5-07)
C13055-01SH5-07 (SH-5-07)
MBS3612104-01KCC-07
MBS3843843-01MM 07
MBS5815614RMS-07
MBS5820498CP-07
BA6425-5.1SH5-07

Popular Products